If you have COVID-19 and are caring for someone or yourself at home, what is the treatment protocol? What is WHO’s guidance on Remdesivir and convalescent plasma therapy? How to monitor oxygen at home and what are the red flags when you should call the doctor? WHO’s Dr Janet Diaz explains in Sci...ence in 5.
more
Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national programme managers, second edition: web annex A: protocol for evaluating minimum package of care of morbidity management and disability prevention for lymphoedema management in designated health facilit...ies.
more
Health is routinely considered in strategic environmental assessment (SEA) and environmental impact assessment (EIA), following requirements of European Union directives and the Protocol on Strategic Environmental Assessment to the Convention on Environmental Impact Assessment in a Trans...boundary Context (Espoo Convention). Policy-makers and other sources report that these assessments mostly adopt a biophysical perspective and that few cases consider or define health in a manner which is consistent with the WHO Constitution, by considering the wider social, economic, behavioural and institutional aspects of health. This systematically conducted review of over 333 SEA and EIA cases in the WHO European Region shows that while about 80% of assessments pursue a narrow, biophysical interpretation of health, around 10% consider wider determinants when defining health, and another 10% consider wider determinants of health in the actual assessment. Twelve case studies are presented, literature is reviewed and implications for practice are considered.
more
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...t of diphtheria. There is a worldwide shortage of DAT and evidence based recommendations on the use of DAT were requested by many Member States.
The guidance also includes new recommendations on antibiotics. In patients with suspected or confirmed diphtheria, WHO recommends using macrolide antibiotics (azithromycin, erythromycin) rather than penicillin antibiotics.
This clinical practice guideline has been rapidly developed recognizing the global increase in diphtheria outbreaks. Outbreaks of diphtheria in Nigeria, Guinea and neighbouring countries in 2023 have highlighted the urgent need for evidence-based clinical practice guidelines for the treatment of diphtheria. Given the sporadic nature of outbreaks, many clinicians in the affected regions have never managed acute diphtheria and its related complications. Diphtheria remains a neglected disease and vaccination is the top priority. At the same time, for patients with diphtheria, access to antibiotics, DAT and supportive care can be lifesaving.
more
El objetivo del presente documento consiste en ofrecer
orientaciones provisionales sobre la definición de los casos
de SGB y las estrategias para tratar el síndrome en el
contexto del brote de virus de Zika y de su posible relación
con el SGB. Asimismo, pretende servir como base para la
elab...oración de protocolos clínicos y políticas sanitarias
locales relacionadas con la atención a los pacientes con
SGB. En marzo de 2016 se organizará una reunión de
expertos para elaborar más orientaciones sobre la
identificación y el tratamiento del SGB y otros posibles
trastornos neurológicos en el contexto de la transmisión del
virus de Zika.
more
En enero de 2020, el agente etiológico responsable de un grupo de casos de neumonía grave en Wuhan, China, fue identificado como un nuevo betacoronavirus (2019-nCoV), distinto del SARS-CoV y MERS-CoV (1) (2) (3). La secuencia genómica completa de este nuevo agente está disponible y se han desarr...ollado diferentes protocolos de detección, aunque aún no se han validado por completo. Sin embargo, a la luz de la posible introducción de un caso sospechoso relacionado con el 2019-nCoV en la Región de las Américas, la Organización Panamericana de la Salud / Organización Mundial de la Salud (OPS / OMS) recomienda a los Estados Miembros garantizar su identificación oportuna, el envío de las muestras a laboratorios Nacionales o de referencia y la implementación del protocolo de detección molecular para 2019-nCoV, según la capacidad del laboratorio.
Hasta la fecha, no es completamente claro el potencial patogénico ni la dinámica de transmisión del 2019nCoV. Por esta razón y a la luz del conocimiento de otros virus similares (MERS-CoV, SARS-CoV), es necesario mantener y fortalecer las medidas de bioseguridad y elementos de protección personal para el trabajo con muestras sospechosas de infección con patógenos respiratorios.
more
Entretanto, à luz da possível introdução de um caso suspeito relacionado ao COVID-19 na Região das Américas, a Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS) recomenda que os Estados-membros garantam sua identificação oportuna, o envio de amostras a laborat...rios nacionais ou de referência e a implementação do protocolo de detecção molecular do COVID-19, dependendo da capacidade do laboratório. Até à data, o potencial patogênico e a dinâmica de transmissão do COVID-19 não são completamente claros. Por esta razão e à luz do conhecimento de outros vírus semelhantes (MERS-CoV, SRA-CoV), é necessário manter e reforçar as medidas de biossegurança e os equipamentos de proteção individual para o trabalho com amostras suspeitas de infecção com patógenos respiratórios.
more
Practical Guide to Occupational Health Management for Covid-19
A Associação Nacional de Medicina do Trabalho – ANAMT e a Secretaria de Gestão do Trabalho e da Educação em Saúde – SGETS/MS, considerando as ações governamentais das instâncias federal, estadual, distrital e municipal para... o enfrentamento da pandemia da COVID -19; as atualizações de protocolos clínico-epidemiológicos da OMS, OPAS, do Ministério da Saúde e as regulamentações publicadas pelas demais autoridades sanitárias brasileiras, resolvem elaborar um Guia Prático de Gestão em Saúde no Trabalho para nortear o Plano de Contingência durante a Pandemia de Covid-19 e a retomada das atividades econômicas no país, com vistas à segurança à saúde do trabalhador e do ambiente de trabalho.
more
The Cartagena Declaration on Refugees was adopted by the Colloquium on the International Protection of Refugees in Central America, Mexico and Panama on November 22, 1984. The declaration is a non-binding agreement but has been incorporated in refugee law in various countries. The Cartagena Declarat...ion on Refugees bases its principles on the “commitments with regards to refugees” defined in the Contadora Act on Peace and Cooperation (which are based on the 1951 UN Refugee Convention and the 1967 Protocol).
It includes a range of detailed commitments to peace, democratization, regional security and economic co-operation. It also provided for regional committees to evaluate and verify compliance with these commitments.
This document contains the Spanish, French and English versions of the original text.
more
Also available in English.
Esta nueva edición del Informe sobre control del tabaco en la Región de las Américas presenta la situación actual y las tendencias de la epidemia del tabaquismo en la Región de las Américas, así como de la aplicación de seis medidas efectivas para combatirla conoc...idas como el paquete de medidas MPOWER. El informe cuenta con las contribuciones de autores invitados, quienes comparten sus puntos de vista sobre temas de alto interés para la Región, como es el Protocolo para la Eliminación del Comercio Ilícito de Productos de Tabaco, la regulación de nuevos (y viejos) productos y lecciones aprendidas. El informe incluye además una sección con perfiles de país, en la que se muestra el estado de aplicación de las seis medidas en cada uno de los 35 Estados Miembros de la Región.
more
En este manual se presenta un método estandarizado para realizar, desde los centros de salud, encuestas transversales que permitan calcular los costos directos e indirectos que afectan a los pacientes con tuberculosis y a sus hogares, a partir de la experiencia acumulada con un instrumento diseñad...o previamente y un protocolo piloto probado por la OMS. El manual está dirigido especialmente a los programas nacionales de tuberculosis y a las entidades que colaboran en la planificación, ejecución, evaluación e Investigación operativa de los programas de tuberculosis.
more
22.12.2015
Pharm - Ed
--
www.Pharm-Ed.net
La solution hydro-alcoolique (SHA) pour l'hygiène des mains fait partie de la liste OMS des médicaments essentiels. La production locale de la SHA est une alternative aux produits commercialisés. Bien qu'elle soit adaptée aux contextes avec ressour...ces limitées, il est essentiel de respecter les règles de bonnes pratiques de fabrication afin de garantir la qualité, l'efficacité et la sécurité du produit.
Cette vidéo pédagogique complète la leçon e-learning sur la formulation et la fabrication de la solution hydro-alcooliquedisponible gratuitement en lciquant sur le lien suivant: https://pharmed.datapharma.ch/courses.... Les protocoles de fabrication, la liste du matériel nécessaire pour la production, les modèles de compte-rendu de fabrication sont également disponible gratuitement sur la plate-forme Pharm-Ed
Vous pouvez désormais suivre pas à pas les étapes de préparation et du contrôle qualité de la SHA en visionnant les chapitres suivants:
00:00 Introduction
01:12 Documentation
01:55 Habillage
03:16 Préparation de la place de travail
04:41 Mesure
07:19 Mélange
09:52 Contrôle qualité
13:45 Conditionnement et étiquetage
15:41 Mise en quarantaine et nettoyage
Pour d'avantage d'informations rendez-vous sur
https://www.Pharm-Ed.net
Pharm-Ed est une initiative de la Pharmacie des Hôpitaux Universitaires de Genève en Suisse.
more
Dans le plan stratégique de lutte contre le paludisme 2011-2015 révisé en 2013,
le Burkina Faso a retenu les axes stratégiques suivants: la prise en charge des
cas de paludisme, le traitement préventif intermittent du paludisme chez les
femmes enceintes et les enfants, la chimio prévention ...du paludisme saisonnier
(CPS), la lutte contre les vecteurs, la gestion de l’approvisionnement des
produits de lutte contre le paludisme, la communication, le suivi-évaluationrecherche et la gestion du programme.
Directives nationales de prise en charge du paludisme 6
L’objectif des présentes directives est de standardiser les protocoles de prise en
charge du paludisme dans le but de contribuer à la réduction de la morbidité et
de la mortalité liées à cette maladie. Ces directives traitent spécifiquement de la
définition de cas, de la classification des formes cliniques, des modalités de prise
en charge des cas, des modalités de la prévention du paludisme pendant la
grossesse et chez le nourrisson, et enfin du suivi-évaluation des activités de
prise en charge du paludisme.
more
medPPE est une application pour les dispositifs Android et iOS dans laquelle les personnels de santé trouveront les informations nécessaires sur les équipements de protection individuelle (EPI), suggérés par l'OPS/OMS, qui doivent être utilisés selon la fonction et l'activité réalisée dans... le cadre de la prise en charge de patients atteints de maladies transmises par gouttelettes et par contact, telles que la COVID-19, ou lors de procédures génératrices d'aérosols.
Les mesures d'hygiène des mains et les procédures d'habillage-déshabillage pour l’utilisation de l’EPI, ainsi que les protocoles d'élimination et de gestion des déchets doivent être suivies. La diffusion d’information et la formation du personnel de santé et des responsables administratifs, ainsi que la signalétique, l’information et l’éducation des patients et de leurs proches sont tout aussi importants.
Vous pouvez télécharger le application pour iOS et Android
more
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there... is a category of medicines that faces a unique challenge in terms of availability. These are the medicines governed by the international conventions on narcotic and psychotropic substances. “Controlled medicines” is the common definition for pharmaceuticals whose active principles are listed under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol, such as morphine and methadone; the 1971 United Nations Convention on Psychotropic Substances, such as diazepam and buprenorphine; and the 1988 United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, such as ergometrine and ephedrine. The conventions list substances in “Schedules” according to their different levels of potential for abuse and harm, and the commensurate severity of control measures to be applied by countries.
more
PAHO has systematically identified and collected basic information on all investigations related to Zika, both those already published and those on track to be published.
Each study has been categorized in the areas of virus, vectors and reservoirs; epidemiology; disease pathogenesis and consequen...ces of Zika infection; clinical management; public health interventions; health systems and services response; research and product development; and causality. You can also search by publication type: published articles, protocol and publication of preliminary results.
more
Study Report August 2014
Curatio International Foundation (CIF) and the Association Tanadgoma would like to acknowledge the financial support provided by GFATM under the project “Establishment of evidence base for national HIV/AIDS program by strengthening of HIV/AIDS surveillance system in t...he country” (GEO-H-GPIC), which made this study possible.
The report was prepared by Dr. Ivdity Chikovani, Dr. Natia Shengelia, Lela Sulaberidze (CIF) and Nino Tsereteli (Tanadgoma).
Special thanks are extended to international consultants – Ali Mirzazadeh (MD, MPH, PhD Postdoctoral Scholar, University of California, San Francisco Institute for Health Policy Studies & Global Health Sciences) for his significant contribution in study preparation, protocol and questionnaire design and data analysis and Abu S. Abdul-Quader (PhD, Epidemiologist, Global AIDS Program Centers for Disease Control and Prevention) for his valuable input in refining methodology and overall guidance during the study implementation.
Special thanks are extended to international consultants – Abu S. Abdul-Quader (PhD, Epidemiologist, Global AIDS Program, Centers for Disease Control and Prevention) for his valuable input in refining methodology and overall guidance during the study implementation and Ali Mirzazadeh (MD, MPH, PhD Postdoctoral Scholar, University of California, San Francisco Institute for Health Policy Studies & Global Health Sciences) for his significant contribution in the NSU study preparation, protocol and questionnaire design and data analysis.
Authors appreciate a highly professional work of Tanadgoma staff: the survey coordinator KhatunaKhazhomia; the interviewers: Ketevan Tchelidze, Nino Kipiani, Koba Bitsadze, Kakhaber Akhvlediani, ZazaBabunashvili, Rati Tsintsadze and the social workers: Archil Rekhviashvili, Tea Chakhrakia, Irina Bregvadze, Kakhaber Kepuladze, Ketevan Jibladze and Shota Makharadze for their input in the recruitment process.
more
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...demic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo.
WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.
more
Accessed: 02.05.2020
These consolidated guidelines provide recommendations for comprehensive prevention and case management strategies in Kenya
Scope of the Guidelines: Infection prevention and control Patient triage Emergency Medical Services Case management Laboratory testing algorithm
Target... Audience: Health care workers taking care of patients suspected or confirmed to have COVID-19
These guidelines combine both preventive and clinical management of the disease in Kenyan context. The protocol borrows various international recommendations including the World Health Organization, from experience of other countries such as China that has struggled with the outbreak for a longer time and from principles of virology and infectious disease management.
more
FIND conducted independent evaluations at the University Hospitals of Geneva (HUG), to verify the limit of detection (LOD) and the clinical performance (as reported by the manufacturers) of the following molecular test kits. The LOD analysis was performed using cultured viral stocks from a clinical ...isolate from Switzerland, and quantified using an E gene standard. The clinical performance analysis was conducted on extracted samples from individuals suspected to have COVID-19 that were tested using an in-house PCR protocol that was optimized based on the Tib Molbiol assay.
more